Nichol Ochsner | Vice President-Investor Relations |
Robert Finizio | Chief Executive Officer |
Daniel Cartwright | Chief Financial Officer |
Dr. Brian Bernick | Co-Founder |
Dr. Sebastian Mirkin | Chief Medical Officer |
Dawn Halkuff | Chief Commercial Officer |
Ken Cacciatore | Cowen & Company |
Annabel Samimy | Stifel |
Jay Olson | Oppenheimer & Co. |
Bill Tanner | Cantor Fitzgerald |
Good afternoon, ladies and gentlemen and thank you for joining us for the TherapeuticsMD’s Third Quarter 2018 Financial Results Conference Call.
Following prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations, Nichol Ochsner. Nichol?
Good afternoon, everyone.